Zacharias M, Konjic S, Kratochwill N, Absenger G, Terbuch A, Jost P
Cancers (Basel). 2024; 16(5).
PMID: 38473263
PMC: 10931067.
DOI: 10.3390/cancers16050903.
Yang Y, Liu H, Liu T, Zheng X, Wu B, Zhou D
Front Oncol. 2023; 13:1209799.
PMID: 37637057
PMC: 10450948.
DOI: 10.3389/fonc.2023.1209799.
Wang C, Yuan X, Xue J
Mol Ther. 2023; 31(7):1960-1978.
PMID: 37179456
PMC: 10362419.
DOI: 10.1016/j.ymthe.2023.05.007.
Savari O, Chang J, Bishop J, Sakthivel M, Askin F, Rekhtman N
J Thorac Oncol. 2022; 17(8):1050-1053.
PMID: 35773081
PMC: 9357138.
DOI: 10.1016/j.jtho.2022.05.009.
Cheng Y, Yang J, Wang D, Yan D
Ann Transl Med. 2022; 10(3):157.
PMID: 35284560
PMC: 8904988.
DOI: 10.21037/atm-21-6754.
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report.
Ball M, Christopoulos P, Kirchner M, Allgauer M, Brandt R, Winter H
Cold Spring Harb Mol Case Stud. 2022; 8(3).
PMID: 35058282
PMC: 9059782.
DOI: 10.1101/mcs.a006156.
An autopsy case of anaplastic lymphoma kinase-positive lung cancer exacerbated in a short period of time: a case report.
Takeda M, Sato K, Sakamoto S, Suzuki M, Izumiya Y, Kumagai N
J Med Case Rep. 2019; 13(1):118.
PMID: 31030664
PMC: 6487583.
DOI: 10.1186/s13256-019-2054-3.
Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review.
Zhang B, Zhang Y, Xu J, Zhang X, Chu T, Wang S
Target Oncol. 2018; 13(5):631-639.
PMID: 30218431
DOI: 10.1007/s11523-018-0592-z.
Adenosquamous carcinoma of the lung.
Li C, Lu H
Onco Targets Ther. 2018; 11:4829-4835.
PMID: 30147334
PMC: 6098426.
DOI: 10.2147/OTT.S164574.
Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review.
Watanabe J, Togo S, Sumiyoshi I, Namba Y, Suina K, Mizuno T
Oncotarget. 2018; 9(35):24000-24013.
PMID: 29844868
PMC: 5963613.
DOI: 10.18632/oncotarget.25257.
Response to crizotinib in a squamous cell lung carcinoma patient harbouring echinoderm microtubule-associated protein-like 4-anaplastic lymphoma translocation: A case report.
Wang W, Song Z, Zhang Y
Thorac Cancer. 2016; 7(3):355-7.
PMID: 27148422
PMC: 4846625.
DOI: 10.1111/1759-7714.12298.
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib.
Hembrough T, Liao W, Hartley C, Ma P, Velcheti V, Lanigan C
Clin Chem. 2015; 62(1):252-61.
PMID: 26585927
PMC: 4760638.
DOI: 10.1373/clinchem.2015.245860.
Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
Marino F, Liguori G, Aquino G, La Mantia E, Bosari S, Ferrero S
PLoS One. 2015; 10(9):e0139264.
PMID: 26422230
PMC: 4589235.
DOI: 10.1371/journal.pone.0139264.
Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.
Hellmann M, Chaft J, Rusch V, Ginsberg M, Finley D, Kris M
Cancer Chemother Pharmacol. 2013; 72(2):453-61.
PMID: 23811982
PMC: 4653739.
DOI: 10.1007/s00280-013-2219-5.
ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement.
Kim H, Park E, Kim Y, Chung J
Virchows Arch. 2013; 462(5):597-9.
PMID: 23605565
DOI: 10.1007/s00428-013-1413-5.
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular....
Lindeman N, Cagle P, Beasley M, Chitale D, Dacic S, Giaccone G
J Thorac Oncol. 2013; 8(7):823-59.
PMID: 23552377
PMC: 4159960.
DOI: 10.1097/JTO.0b013e318290868f.
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular....
Lindeman N, Cagle P, Beasley M, Chitale D, Dacic S, Giaccone G
Arch Pathol Lab Med. 2013; 137(6):828-60.
PMID: 23551194
PMC: 4162344.
DOI: 10.5858/arpa.2012-0720-OA.
